Champlain Investment Partners’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,450,802
Closed -$50.7M 143
2025
Q1
$50.7M Sell
1,450,802
-22,837
-2% -$905K 0.37% 106
2024
Q4
$65.6M Sell
1,473,639
-73,365
-5% -$3.3M 0.42% 94
2024
Q3
$67.4M Sell
1,547,004
-176,821
-10% -$6.66M 0.41% 90
2024
Q2
$46.7M Sell
1,723,825
-29,380
-2% -$851K 0.29% 110
2024
Q1
$51.2M Buy
1,753,205
+241,235
+16% +$7.31M 0.29% 109
2023
Q4
$56.9M Sell
1,511,970
-72,450
-5% -$2.66M 0.34% 101
2023
Q3
$71.4M Buy
1,584,420
+576,068
+57% +$34.9M 0.46% 88
2023
Q2
$74.3M Buy
1,008,352
+24,357
+2% +$1.64M 0.46% 89
2023
Q1
$57.7M Buy
983,995
+281,305
+40% +$15.5M 0.36% 98
2022
Q4
$35.4M Sell
702,690
-22,700
-3% -$1.36M 0.23% 119
2022
Q3
$63.1M Buy
725,390
+146,870
+25% +$15.4M 0.43% 95
2022
Q2
$65.8M Buy
578,520
+117,795
+26% +$13.5M 0.43% 96
2022
Q1
$59.7M Buy
460,725
+41,710
+10% +$6.01M 0.31% 109
2021
Q4
$75.6M Sell
419,015
-60,485
-13% -$10.5M 0.34% 105
2021
Q3
$71.2M Sell
479,500
-130,015
-21% -$19.9M 0.34% 109
2021
Q2
$92.3M Sell
609,515
-1,030
-0.2% -$143K 0.44% 97
2021
Q1
$79.3M Buy
610,545
+67,450
+12% +$8.65M 0.41% 101
2020
Q4
$65.2M Sell
543,095
-42,520
-7% -$4.17M 0.37% 91
2020
Q3
$43.7M Buy
+585,615
New +$40.6M 0.3% 103
2019
Q3
Sell
-101,095
Closed -$8.7M 122
2019
Q2
$8.7M Sell
101,095
-152,710
-60% -$12.4M 0.07% 111
2019
Q1
$20.5M Sell
253,805
-316,690
-56% -$23.7M 0.18% 112
2018
Q4
$34.9M Sell
570,495
-393,265
-41% -$26.6M 0.36% 97
2018
Q3
$69.3M Sell
963,760
-356,720
-27% -$22.5M 0.61% 75
2018
Q2
$69.3M Sell
1,320,480
-184,965
-12% -$8.7M 0.67% 68
2018
Q1
$65.3M Buy
1,505,445
+46,390
+3% +$2.13M 0.71% 62
2017
Q4
$70.8M Sell
1,459,055
-13,290
-0.9% -$671K 0.8% 57
2017
Q3
$75.2M Sell
1,472,345
-183,628
-11% -$8.8M 0.89% 49
2017
Q2
$71.4M Sell
1,655,973
-42,167
-2% -$1.75M 0.87% 48
2017
Q1
$69M Buy
1,698,140
+99,075
+6% +$3.65M 0.91% 45
2016
Q4
$54.2M Buy
1,599,065
+278,495
+21% +$9.58M 0.75% 57
2016
Q3
$50.6M Sell
1,320,570
-90,810
-6% -$3.39M 0.77% 50
2016
Q2
$48.3M Sell
1,411,380
-17,340
-1% -$541K 0.83% 47
2016
Q1
$39.8M Sell
1,428,720
-149,850
-9% -$4.12M 0.72% 59
2015
Q4
$49.1M Buy
1,578,570
+121,241
+8% +$3.58M 0.84% 46
2015
Q3
$45.3M Buy
1,457,329
+177,094
+14% +$6.34M 0.79% 57
2015
Q2
$48.3M Sell
1,280,235
-36,225
-3% -$1.32M 0.76% 57
2015
Q1
$46.2M Buy
1,316,460
+180,485
+16% +$5.95M 0.79% 50
2014
Q4
$37.6M Buy
1,135,975
+87,100
+8% +$2.69M 0.6% 78
2014
Q3
$28.7M Buy
1,048,875
+127,870
+14% +$3.5M 0.5% 92
2014
Q2
$26.4M Buy
921,005
+121,285
+15% +$3.27M 0.43% 101
2014
Q1
$22.9M Sell
799,720
-18,035
-2% -$493K 0.39% 103
2013
Q4
$20.9M Buy
817,755
+698,145
+584% +$16.7M 0.37% 104
2013
Q3
$2.83M Buy
+119,610
New +$2.67M 0.05% 129

Other funds holding OMCL

Champlain Investment Partners's OMCL Position: Q2 2025 in Review

Champlain Investment Partners sold out of Omnicell (OMCL) in Q2 2025, closing a stake of 1,450,802 shares — an estimated $50.7M sold.

Champlain Investment Partners first reported a position in OMCL in Q3 2013 and held it in 43 quarters. The position peaked at $92.3M in Q2 2021. 247 funds tracked by Wall St. Rank hold OMCL as of Q2 2025.

  • Champlain Investment Partners reported no remaining Omnicell position as of Q2 2025 after selling out during the quarter.
  • Champlain Investment Partners sold 1,450,802 Omnicell shares in Q2 2025, an estimated $50.7M.
  • Champlain Investment Partners first reported a position in Omnicell in Q3 2013 and held it in 43 quarters.
  • Champlain Investment Partners's Omnicell position peaked at $92.3M in Q2 2021.
  • 247 funds tracked by Wall St. Rank held Omnicell as of Q2 2025.

Based on Champlain Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.